Trial Profile
A phase I, single dose trial of TW 001 for treatment of amyotrophic lateral sclerosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Edaravone (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- 15 Dec 2015 New trial record
- 10 Dec 2015 Results published in the Media Release